Tag Archives: genomics-based medicine

Imagine the Potential: The World’s First Online Hub for Global Genomic Data Access

Posted on by
The NextCODE Exchange, a new browser-based hub, allows for real-time sharing of whole genome collections in a simple, consistent format.

The NextCODE Exchange, a new browser-based hub, allows for real-time sharing of whole genome collections in a simple, consistent format.

The field of genomic medicine is rapidly advancing as the research community becomes more comfortable manipulating genomic data with the goal of discovering insights about disease causes and risks. Yet each database is hosted within separate organizations, organized in unique ways and vastly too cumbersome to easily share with others who may be working on similar research.

This weekend a new tool launched to enable just that. The NextCODE Exchange (see release here), a new browser-based hub, allows for real-time sharing of whole genome collections in a simple, consistent format.

The availability of this Exchange is a critical advance in extending the utility of genomic data by allowing organizations around the world to access and harmonize large complementary datasets, potentially multiplying their study data sets to gain more reliable insights than ever before.

Already, numerous organizations are participating in the NextCODE Exchange to add and share their genomic data, including clinicians and researchers affiliated with Boston Children’s Hospital, University College Dublin, Queensland Institute of Medical Research (Australia), and Saitama Medical University (Japan).

As new institutions look to the Exchange to share genomic data, this hub holds significant potential to help advance progress in genomic-based medicine.

Learn more about the NextCODE Exchange here.

Share on Tumblr
0
email

Genomics-Based Medicine Coming Into View

Posted on by
NextCODE Health

NextCODE Health has quickly gained recognition for its unique capabilities to address unmet needs in the genomics space through a massive genomics database that interprets DNA samples to identify relevant disease markers.

The practice and adoption of genomic medicine is accelerating as technologies improve, costs fall and new insights drive better patient care. While many companies are supporting this emerging field, a select few are providing the unique perspectives and capabilities to advance progress even faster.

NextCODE Health made headlines less than a year ago with the announcement of its launch and funding by major investors in healthcare and biotechnology. The company quickly gained recognition for its unique capabilities to address unmet needs in the genomics space through a massive genomics database that interprets DNA samples to identify relevant disease markers. (See the features in Xconomy, Bio-IT World and PLOS Blog.) The company was later mentioned in Nature Biotechnology News for its potential contributions to genome studies by leveraging key reference data from deCODE’s Icelandic work in Iceland.

Its rapid trajectory since launch and the utility of its genomic analysis technology was featured in BioCentury in May, featuring testimonials from clinicians using NextCODE capabilities to diagnose patients at Boston Children’s Hospital, the Baylor College of Medicine, and the Sanford School of Medicine. In June, it was featured in a major interview with Bio-IT World and the company continues to expand. Since then, NextCODE has announced several programs through which global pioneers in clinical genomics research are applying its interpretation and analysis technology to support research and diagnosis in rare diseases, including:

As more organizations employ genomics in major research initiatives, NextCODE’s interpretation technology will be an increasingly important asset in delivering meaningful insights from the wealth of genomic data being produced. Visit NextCode for the latest on how the future of genomics-based medicine continues to evolve.